Nimodipine attenuation of early brain dysfunctions is partially related to its inverting acute vasospasm in a cisterna magna subarachnoid hemorrhage (SAH) model in rats
- PMID: 22694164
- DOI: 10.3109/00207454.2012.700661
Nimodipine attenuation of early brain dysfunctions is partially related to its inverting acute vasospasm in a cisterna magna subarachnoid hemorrhage (SAH) model in rats
Abstract
Subarachnoid hemorrhage (SAH)-induced brain injury is highly related to neurological deficits and mortality. Regional cerebral blood flow (rCBF) changes and vasoconstriction are two complications that occur soon after SAH experimentally. In this study we investigated the changes in rCBF and vertebro-basilar arterial diameter in a cisterna megna SAH model in Sprague-Dawley rats and intended to explore whether improving early rCBF reduction and cerebral vasospasm could contribute to alleviating blood-brain barrier (BBB) dysfunction. In rats for rCBF, vasospasm and BBB permeability assessments, nimodipine (NDP) or saline was administered intravenously 5 minutes after SAH. rCBF within the first 60 minutes after SAH was measured by laser Doppler flowmetry. BBB permeability indexed by Evans Blue extravasation was assessed 4 hours after SAH. Angiography for the caliber changes of the vertebro-basilar artery were conducted 30 minutes post SAH. Pronounced rCBF reduction and vasospasm were observed soon after SAH, followed by BBB permeability increment. NDP administration could improve rCBF and attenuate vasospasm, followed by the alleviation of BBB permeability. Our results demonstrate that early improvement of cerebral circulation by NDP may contribute to the reduction in brain injury indexed by BBB disruption.
Similar articles
-
The effects of nimodipine on regional cerebral blood flow, brain water and electrolyte contents in rats with subarachnoid hemorrhage.Clin Hemorheol Microcirc. 2003;29(3-4):337-44. Clin Hemorheol Microcirc. 2003. PMID: 14724359
-
The effect of an adenosine A1 receptor agonist in the treatment of experimental subarachnoid hemorrhage-induced cerebrovasospasm.Acta Neurochir (Wien). 2006 Aug;148(8):873-9; discussion 879. doi: 10.1007/s00701-006-0793-6. Epub 2006 Jun 23. Acta Neurochir (Wien). 2006. PMID: 16791438
-
Clazosentan, an endothelin receptor antagonist, prevents early hypoperfusion during the acute phase of massive experimental subarachnoid hemorrhage: a laser Doppler flowmetry study in rats.J Neurosurg. 2008 Dec;109(6):1134-40. doi: 10.3171/JNS.2008.109.12.1134. J Neurosurg. 2008. PMID: 19035733
-
The single and double blood injection rabbit subarachnoid hemorrhage model.Transl Stroke Res. 2015 Feb;6(1):88-97. doi: 10.1007/s12975-014-0375-5. Epub 2014 Nov 8. Transl Stroke Res. 2015. PMID: 25381219 Review.
-
The rabbit blood shunt subarachnoid haemorrhage model.Acta Neurochir Suppl. 2015;120:337-42. doi: 10.1007/978-3-319-04981-6_58. Acta Neurochir Suppl. 2015. PMID: 25366648 Review.
Cited by
-
Calcium and potassium channels in experimental subarachnoid hemorrhage and transient global ischemia.Stroke Res Treat. 2012;2012:382146. doi: 10.1155/2012/382146. Epub 2012 Dec 9. Stroke Res Treat. 2012. PMID: 23251831 Free PMC article.
-
Multimodal MRI characterization of experimental subarachnoid hemorrhage.Neuroscience. 2016 Mar 1;316:53-62. doi: 10.1016/j.neuroscience.2015.12.027. Epub 2015 Dec 18. Neuroscience. 2016. PMID: 26708744 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources